IJzerman AP - Search Results

1

Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding.

van der Klein PA, Kourounakis AP, IJzerman AP. van der Klein PA, et al. Among authors: ijzerman ap. J Med Chem. 1999 Sep 9;42(18):3629-35. doi: 10.1021/jm991051d. J Med Chem. 1999. PMID: 10479294

2

Allosteric modulation of G protein-coupled receptors.

Ijzerman A, Kourounakis A, van der Klein P. Ijzerman A, et al. Farmaco. 2001 Jan-Feb;56(1-2):67-70. doi: 10.1016/s0014-827x(01)01015-1. Farmaco. 2001. PMID: 11347969

3

Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptor.

Xia L, de Vries H, IJzerman AP, Heitman LH. Xia L, et al. Among authors: ijzerman ap. Purinergic Signal. 2016 Mar;12(1):115-26. doi: 10.1007/s11302-015-9485-0. Epub 2015 Dec 9. Purinergic Signal. 2016. PMID: 26647040 Free PMC article.

4

A covalent antagonist for the human adenosine A_2A receptor.

Yang X, Dong G, Michiels TJM, Lenselink EB, Heitman L, Louvel J, IJzerman AP. Yang X, et al. Among authors: ijzerman ap. Purinergic Signal. 2017 Jun;13(2):191-201. doi: 10.1007/s11302-016-9549-9. Epub 2016 Dec 3. Purinergic Signal. 2017. PMID: 27915383 Free PMC article.

5

New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.

Beukers MW, Chang LC, von Frijtag Drabbe Künzel JK, Mulder-Krieger T, Spanjersberg RF, Brussee J, IJzerman AP. Beukers MW, et al. Among authors: ijzerman ap. J Med Chem. 2004 Jul 15;47(15):3707-9. doi: 10.1021/jm049947s. J Med Chem. 2004. PMID: 15239649

6

Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists.

Priego EM, von Frijtag Drabbe Kuenzel J, IJzerman AP, Camarasa MJ, Pérez-Pérez MJ. Priego EM, et al. Among authors: ijzerman ap. J Med Chem. 2002 Aug 1;45(16):3337-44. doi: 10.1021/jm0208469. J Med Chem. 2002. PMID: 12139445

7

Medicinal chemistry of adenosine A1 receptor ligands.

Soudijn W, van Wijngaarden I, IJzerman AP. Soudijn W, et al. Among authors: ijzerman ap. Curr Top Med Chem. 2003;3(4):355-67. doi: 10.2174/1568026033392165. Curr Top Med Chem. 2003. PMID: 12570755 Review.

8

Synthesis and biological evaluation of disubstituted N6-cyclopentyladenine analogues: the search for a neutral antagonist with high affinity for the adenosine A1 receptor.

de Ligt RA, van der Klein PA, von Frijtag Drabbe Künzel JK, Lorenzen A, Ait El Maate F, Fujikawa S, van Westhoven R, van den Hoven T, Brussee J, IJzerman AP. de Ligt RA, et al. Among authors: ijzerman ap. Bioorg Med Chem. 2004 Jan 2;12(1):139-49. doi: 10.1016/j.bmc.2003.10.023. Bioorg Med Chem. 2004. PMID: 14697779

9

Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic space.

van der Horst E, Peironcely JE, van Westen GJ, van den Hoven OO, Galloway WR, Spring DR, Wegner JK, van Vlijmen HW, Ijzerman AP, Overington JP, Bender A. van der Horst E, et al. Among authors: ijzerman ap. Curr Top Med Chem. 2011;11(15):1964-77. doi: 10.2174/156802611796391230. Curr Top Med Chem. 2011. PMID: 21470175 Review.

10

Allosteric modulation of adenosine receptors.

Göblyös A, Ijzerman AP. Göblyös A, et al. Among authors: ijzerman ap. Biochim Biophys Acta. 2011 May;1808(5):1309-18. doi: 10.1016/j.bbamem.2010.06.013. Epub 2010 Jun 27. Biochim Biophys Acta. 2011. PMID: 20599682 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results